IP Library › Granted Patent US 9,066,502
Granted Patent B2
US 9,066,502 · App. 14/132,412 · Granted Jun 30, 2015

Hybrid light chain mice

Inventors: Lynn Macdonald (White Plains, NY); Sean Stevens (San Diego, CA); Cagan Gurer (Valhalla, NY); Andrew J. Murphy (Croton-on-Hudson, NY); Karolina A. Meagher (Tarrytown, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
A01K67/0278A01K67/0275A01K2217/05A01K2227/105A01K2267/01A01K2267/0381C07K16/00C07K16/462C07K2317/21C07K2317/24C07K2317/515C12N15/8509A01K2267/02C07K16/18C07K16/461
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,066,502
App. No.
14/132,412
Granted
Jun 30, 2015
Kind
B2
Abstract

Genetically modified mice are provided that express human λ variable (hVλ) sequences, including mice that express hVλ sequences from an endogenous mouse λ light chain locus, mice that express hVλ sequences from an endogenous mouse κ light chain locus, and mice that express hVλ sequences from a transgene or an episome wherein the hVλ sequence is linked to a mouse constant sequence. Mice are provided that are a source of somatically mutated human λ variable sequences useful for making antigen-binding proteins. Compositions and methods for making antigen-binding proteins that comprise human λ variable sequences, including human antibodies, are provided.

Claims (21)

1. An isolated mouse cell comprising at an endogenous κ light chain locus in its genome:

(a) an unrearranged light chain variable region comprising a plurality of contiguous unrearranged functional human λ light chain V (hVλ) gene segments and a plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments, wherein the plurality of hVλ gene segments and the plurality of hJλ gene segments are the only functional variable region gene segments in the unrearranged light chain variable region; and

(b) a mouse K light chain constant region gene,

wherein the plurality of contiguous unrearranged functional human λ light chain V (hVλ) gene segments and the plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments are operably linked to the mouse κ light chain constant region gene.

2. The isolated mouse cell of claim 1 , wherein the cell is an embryonic stem cell.

3. The isolated mouse cell of claim 1 , wherein the plurality of unrearranged hVλ gene segments are at least 12 hVλ gene segments.

4. The isolated mouse cell of claim 1 , wherein the plurality of hJλ gene segments are selected from the group consisting of Jλ1, Jλ2, Jλ3, Jλ7, and a combination thereof.

5. The isolated mouse cell of claim 1 , wherein an endogenous mouse λ light chain locus is deleted in whole or in part.

6. The isolated mouse cell of claim 1 , wherein the unrearranged light chain variable region comprises a human Vκ-Jκ intergenic region from a human κ light chain locus located downstream of the most 3′ hVλ gene segment and upstream of the most 5′ hJλ gene segment.

7. The isolated mouse cell of claim 6 , wherein the human Vκ-Jκ intergenic region comprises SEQ ID NO: 100.

8. The isolated mouse cell of claim 1 , wherein the plurality of hJλ gene segments comprises 4 hJλ gene segments.

9. The isolated mouse cell of claim 8 , wherein the 4 hJλ gene segments are Jλ1, Jλ2, Jλ3 and Jλ7.

10. An isolated mouse cell comprising at an endogenous κ light chain locus in its genome:

(a) an unrearranged light chain variable region comprising:

(i) at least 12 contiguous unrearranged functional human λ light chain variable region (hVλ) gene segments and a plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments, wherein the at least 12 functional hVλ gene segments and the plurality of functional hJλ gene segments are the only functional variable region gene segments in the unrearranged light chain variable region; and

(ii) a human Vκ-Jκ intergenic sequence located between the contiguous hVλ gene segments and the plurality of contiguous hJλ gene segments; and

(b) a mouse κ light chain constant region gene;

wherein the at least 12 contiguous unrearranged functional human λ light chain V (hVλ) gene segments and the plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments are operably linked to the mouse κ light chain constant region gene.

11. The isolated mouse cell of claim 10 , wherein the cell is an embryonic stem cell.

12. The isolated mouse cell of claim 10 , wherein the plurality of hJλ gene segments comprises 4 hJλ gene segments.

13. The isolated mouse cell of claim 12 , wherein the 4 hJλ gene segments are Jλ1, Jλ2, Jλ3 and Jλ7.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE INVENTOR NAME PREVIOUSLY RECORDED AT REEL: 031924 FRAME: 0911. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 7, 2014
From: MACDONALD, LYNN; STEVENS, SEAN; GURER, CAGAN; MURPHY, ANDREW J.; MEAGHER, KAROLINA A.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 033907/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2014
From: MACDONALD, LYNN; STEVENS, SEAN; GURER, CAGAN; MURPHY, ANDREW J.; HOSIAWA, KAROLINA A.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 031924/0911 →
Continuity (4)
Continuation 13166200 · Jun 22, 2011
Provisional Application 61357314 · Jun 22, 2010
Provisional Application 61357317 · Jun 22, 2010
Related Publication 20140137275A1 · May 15, 2014